Abstract

Previously, we demonstrated that 5,5-diphenyl-2-thiohydantoin (DPTH) exerts an anti-proliferation effect on subcultured human umbilical vein endothelial cells (HUVEC). In the present study, we show that 2(naphthalen-2-ylmethylsulfanyl)-5,5-diphenyl-1,5-dihydro-imidazol-4-one (DPTH-N10), a derivative compound of DPTH, exerts a 5 times stronger inhibition of [3H]thymidine incorporation into HUVEC as compared with DPTH and at very low concentrations (0-20 μM) inhibited DNA synthesis and decreased cell number in cultured HUVEC in a concentration- and time-dependent manner, but not in human fibroblasts. [3H]thymidine incorporation analysis demonstrated that treatment of HUVEC with DPTH-N10 arrested the cell at the G0/G1 phase of the cell cycle. Western blot analysis revealed that the protein level of p21 in HUVEC increased after DPTH-N10 treatment. In contrast, the protein levels of p27, p53, cyclins A, D1, D3 and E, cyclin-dependent kinase (CDK)2, and CDK4 in HUVEC were not changed significantly after DPTH-N10 treatment. Immunoprecipitation showed that the formation of the CDK2-p21 complex, but not the CDK2-p27, CDK4-p21, and CDK4-p27 complex, was increased in the DPTH-N10-treated HUVEC. Kinase assay further demonstrated that CDK2, but not CDK4, kinase activity was decreased in the DPTH-N10-treated HUVEC. Pretreatment of HUVEC with a p21, but not p27, antisense oligonucleotide reversed the DPTH-N10-induced inhibition of [3H]thymidine incorporation into HUVEC. Taken together, these data suggest that DPTH-N10 inhibits HUVEC proliferation by increasing the level of p21 protein, which in turn inhibits CDK2 kinase activity, and finally interrupts the cell cycle. Capillary-like tube formation, aortic ring culture, and chick embryo chorioallantoic membrane (CAM) assays further demonstrated the anti-angiogenic effect of DPTH-N10.

Original languageEnglish
Pages (from-to)294-305
Number of pages12
JournalCancer Letters
Volume271
Issue number2
DOIs
Publication statusPublished - Nov 28 2008

Fingerprint

Human Umbilical Vein Endothelial Cells
Thiohydantoins
Thymidine
Phosphotransferases
Cell Cycle
5,5-diphenyl-2-thiohydantoin-N10
Cyclin-Dependent Kinase 2
Chorioallantoic Membrane
Cyclin A
Cyclin E
Cell Cycle Resting Phase
Proteins
Antisense Oligonucleotides
Cyclin D1
G1 Phase
Chick Embryo
Immunoprecipitation
Fibroblasts
Cell Count
Western Blotting

Keywords

  • Angiogenesis
  • Cyclin-dependent kinase
  • Endothelial cells
  • p21
  • Proliferation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Anti-angiogenic action of 5,5-diphenyl-2-thiohydantoin-N10 (DPTH-N10). / Liu, Yuan; Wu, Jender; Ho, Pei Yin; Chen, Li Ching; Chen, Chiung Tong; Liang, Yu Chih; Cheng, Cheng Kuo; Lee, Wen Sen.

In: Cancer Letters, Vol. 271, No. 2, 28.11.2008, p. 294-305.

Research output: Contribution to journalArticle

Liu, Yuan ; Wu, Jender ; Ho, Pei Yin ; Chen, Li Ching ; Chen, Chiung Tong ; Liang, Yu Chih ; Cheng, Cheng Kuo ; Lee, Wen Sen. / Anti-angiogenic action of 5,5-diphenyl-2-thiohydantoin-N10 (DPTH-N10). In: Cancer Letters. 2008 ; Vol. 271, No. 2. pp. 294-305.
@article{bb3b0bf7cb004676a69473c6f53919f3,
title = "Anti-angiogenic action of 5,5-diphenyl-2-thiohydantoin-N10 (DPTH-N10)",
abstract = "Previously, we demonstrated that 5,5-diphenyl-2-thiohydantoin (DPTH) exerts an anti-proliferation effect on subcultured human umbilical vein endothelial cells (HUVEC). In the present study, we show that 2(naphthalen-2-ylmethylsulfanyl)-5,5-diphenyl-1,5-dihydro-imidazol-4-one (DPTH-N10), a derivative compound of DPTH, exerts a 5 times stronger inhibition of [3H]thymidine incorporation into HUVEC as compared with DPTH and at very low concentrations (0-20 μM) inhibited DNA synthesis and decreased cell number in cultured HUVEC in a concentration- and time-dependent manner, but not in human fibroblasts. [3H]thymidine incorporation analysis demonstrated that treatment of HUVEC with DPTH-N10 arrested the cell at the G0/G1 phase of the cell cycle. Western blot analysis revealed that the protein level of p21 in HUVEC increased after DPTH-N10 treatment. In contrast, the protein levels of p27, p53, cyclins A, D1, D3 and E, cyclin-dependent kinase (CDK)2, and CDK4 in HUVEC were not changed significantly after DPTH-N10 treatment. Immunoprecipitation showed that the formation of the CDK2-p21 complex, but not the CDK2-p27, CDK4-p21, and CDK4-p27 complex, was increased in the DPTH-N10-treated HUVEC. Kinase assay further demonstrated that CDK2, but not CDK4, kinase activity was decreased in the DPTH-N10-treated HUVEC. Pretreatment of HUVEC with a p21, but not p27, antisense oligonucleotide reversed the DPTH-N10-induced inhibition of [3H]thymidine incorporation into HUVEC. Taken together, these data suggest that DPTH-N10 inhibits HUVEC proliferation by increasing the level of p21 protein, which in turn inhibits CDK2 kinase activity, and finally interrupts the cell cycle. Capillary-like tube formation, aortic ring culture, and chick embryo chorioallantoic membrane (CAM) assays further demonstrated the anti-angiogenic effect of DPTH-N10.",
keywords = "Angiogenesis, Cyclin-dependent kinase, Endothelial cells, p21, Proliferation",
author = "Yuan Liu and Jender Wu and Ho, {Pei Yin} and Chen, {Li Ching} and Chen, {Chiung Tong} and Liang, {Yu Chih} and Cheng, {Cheng Kuo} and Lee, {Wen Sen}",
year = "2008",
month = "11",
day = "28",
doi = "10.1016/j.canlet.2008.06.016",
language = "English",
volume = "271",
pages = "294--305",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Anti-angiogenic action of 5,5-diphenyl-2-thiohydantoin-N10 (DPTH-N10)

AU - Liu, Yuan

AU - Wu, Jender

AU - Ho, Pei Yin

AU - Chen, Li Ching

AU - Chen, Chiung Tong

AU - Liang, Yu Chih

AU - Cheng, Cheng Kuo

AU - Lee, Wen Sen

PY - 2008/11/28

Y1 - 2008/11/28

N2 - Previously, we demonstrated that 5,5-diphenyl-2-thiohydantoin (DPTH) exerts an anti-proliferation effect on subcultured human umbilical vein endothelial cells (HUVEC). In the present study, we show that 2(naphthalen-2-ylmethylsulfanyl)-5,5-diphenyl-1,5-dihydro-imidazol-4-one (DPTH-N10), a derivative compound of DPTH, exerts a 5 times stronger inhibition of [3H]thymidine incorporation into HUVEC as compared with DPTH and at very low concentrations (0-20 μM) inhibited DNA synthesis and decreased cell number in cultured HUVEC in a concentration- and time-dependent manner, but not in human fibroblasts. [3H]thymidine incorporation analysis demonstrated that treatment of HUVEC with DPTH-N10 arrested the cell at the G0/G1 phase of the cell cycle. Western blot analysis revealed that the protein level of p21 in HUVEC increased after DPTH-N10 treatment. In contrast, the protein levels of p27, p53, cyclins A, D1, D3 and E, cyclin-dependent kinase (CDK)2, and CDK4 in HUVEC were not changed significantly after DPTH-N10 treatment. Immunoprecipitation showed that the formation of the CDK2-p21 complex, but not the CDK2-p27, CDK4-p21, and CDK4-p27 complex, was increased in the DPTH-N10-treated HUVEC. Kinase assay further demonstrated that CDK2, but not CDK4, kinase activity was decreased in the DPTH-N10-treated HUVEC. Pretreatment of HUVEC with a p21, but not p27, antisense oligonucleotide reversed the DPTH-N10-induced inhibition of [3H]thymidine incorporation into HUVEC. Taken together, these data suggest that DPTH-N10 inhibits HUVEC proliferation by increasing the level of p21 protein, which in turn inhibits CDK2 kinase activity, and finally interrupts the cell cycle. Capillary-like tube formation, aortic ring culture, and chick embryo chorioallantoic membrane (CAM) assays further demonstrated the anti-angiogenic effect of DPTH-N10.

AB - Previously, we demonstrated that 5,5-diphenyl-2-thiohydantoin (DPTH) exerts an anti-proliferation effect on subcultured human umbilical vein endothelial cells (HUVEC). In the present study, we show that 2(naphthalen-2-ylmethylsulfanyl)-5,5-diphenyl-1,5-dihydro-imidazol-4-one (DPTH-N10), a derivative compound of DPTH, exerts a 5 times stronger inhibition of [3H]thymidine incorporation into HUVEC as compared with DPTH and at very low concentrations (0-20 μM) inhibited DNA synthesis and decreased cell number in cultured HUVEC in a concentration- and time-dependent manner, but not in human fibroblasts. [3H]thymidine incorporation analysis demonstrated that treatment of HUVEC with DPTH-N10 arrested the cell at the G0/G1 phase of the cell cycle. Western blot analysis revealed that the protein level of p21 in HUVEC increased after DPTH-N10 treatment. In contrast, the protein levels of p27, p53, cyclins A, D1, D3 and E, cyclin-dependent kinase (CDK)2, and CDK4 in HUVEC were not changed significantly after DPTH-N10 treatment. Immunoprecipitation showed that the formation of the CDK2-p21 complex, but not the CDK2-p27, CDK4-p21, and CDK4-p27 complex, was increased in the DPTH-N10-treated HUVEC. Kinase assay further demonstrated that CDK2, but not CDK4, kinase activity was decreased in the DPTH-N10-treated HUVEC. Pretreatment of HUVEC with a p21, but not p27, antisense oligonucleotide reversed the DPTH-N10-induced inhibition of [3H]thymidine incorporation into HUVEC. Taken together, these data suggest that DPTH-N10 inhibits HUVEC proliferation by increasing the level of p21 protein, which in turn inhibits CDK2 kinase activity, and finally interrupts the cell cycle. Capillary-like tube formation, aortic ring culture, and chick embryo chorioallantoic membrane (CAM) assays further demonstrated the anti-angiogenic effect of DPTH-N10.

KW - Angiogenesis

KW - Cyclin-dependent kinase

KW - Endothelial cells

KW - p21

KW - Proliferation

UR - http://www.scopus.com/inward/record.url?scp=53249109430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53249109430&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2008.06.016

DO - 10.1016/j.canlet.2008.06.016

M3 - Article

C2 - 18649995

AN - SCOPUS:53249109430

VL - 271

SP - 294

EP - 305

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -